About Caliber I.D.
Caliber I.D. is a company based in Andover (United States) founded in 1991. Caliber I.D. has raised $1.08 million across 2 funding rounds. The company has 18 employees. Caliber I.D. offers products and services including VivaScope, VivaNet, VivaCam, and VivaScan. Caliber I.D. operates in a competitive market with competitors including Phase Focus, FotoFinder, MedX Health, DermaLumics and Nurugo, among others.
- Headquarter Andover, United States
- Employees 18
- Stage Public
- SectorsHealthcare
- Website caliberid.com
- Social LinkedIn X Facebook
- Legal Name Caliber Imaging & Diagnostics Inc
- Total Equity Funding$1.08M (USD)
in 2 rounds
- Latest Funding Round$2.79M (USD), Post-IPO
Oct 2019
- Employee Count18
Products & Services of Caliber I.D.
Caliber I.D. offers a comprehensive portfolio of products and services, including VivaScope, VivaNet, VivaCam, and VivaScan.
Device for in-vivo confocal microscopy in diagnostics.
Platform for managing imaging data in healthcare settings.
Camera system for real-time medical diagnostics applications.
Tool for scanning and analyzing medical images quickly.
Funding Insights of Caliber I.D.
Caliber I.D. has successfully raised a total of $1.08M across 2 strategic funding rounds. The most recent funding activity was a Post-IPO round of $2.79 million completed in October 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.08M
- Total Rounds 2
- Last Round Post-IPO — $2.79M
- First Round $1.08M
(Nov 2009)
All 2 funding rounds of Caliber I.D. with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2019 | $2.79M | Post-IPO | – | – | – |
| Nov 2009 | $1.08M | Unspecified | – | – | – |
People of Caliber I.D.
14 people are tracked at Caliber I.D. (7 in leadership, 5 in board & advisors, 2 in team); the tracked headcount is 18.
| Name | Role | Group |
|---|---|---|
Christi Alessi Fox | VP, Clinical Development | Leadership |
L. Michael Hone | Director & CEO | Leadership |
William J. Fox | VP, Technology Operations & CTO | Leadership |
Robert T. Kelley | VP, U.S. Sales | Leadership |
Manuel Poppe | Head of Product-IT | Leadership |
Paul Hemmer | VP, Software Development | Leadership |
Steven Ridge | Vice President of Sales & Marketing - USA | Leadership |
William F. O’Dell | Board Member | Board & advisors |
Rocco Maggiotto | Board Member | Board & advisors |
Daniel M. Siegel | Board Member | Board & advisors |
Paul Stuka | Board Member | Board & advisors |
William J. Shea | Chairman | Board & advisors |
Zachary Baltzer | Sr. Electrical Engineer | Team |
Dower Chin | Senior Software Engineer | Team |
Complete people profiles for Caliber I.D.
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Caliber I.D.
Caliber I.D. is a publicly listed company on the OTC with ticker symbol LCDX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date08 Aug 2014
- Listed onOTCMKTS: LCDX
- Listed entityCALIBER IMAGING & DIAGNOSTICS INC
- Exchange sectorHealth technology
- ISINUS13001C1053
- Share price$0.00 (+500% on the day) · 2026-10-08
- Market capitalisation$5,104.00
- Volume (last session)154
Timeline of Caliber I.D.
4 dated milestones of Caliber I.D. across 28 years, from founding to its latest funding, stage changes and deals.
- Founded Caliber I.D. is founded.
- Funding First funding round of $1.1M.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Post-IPO, of $2.8M.
Competitors of Caliber I.D.
Caliber I.D. operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Phase Focus, FotoFinder, MedX Health, DermaLumics and Nurugo, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| phasefocus.com | 2006 | Sheffield, United Kingdom | $12.08M | 10 | Provider of virtual lens that generates High definition images without high-quality lenses | |
| fotofinder.de | 1991 | Bad Birnbach, Germany | – | 101 | Image-based technologies for early digital diagnostics in dermatology and aesthetics | |
| medxhealth.com | 1999 | Mississauga, Canada | – | – | Skin analysis systems for moles and lesions are developed non-invasively. | |
| dermalumics.com | 2015 | Madrid, Spain | – | – | Offers an OCT imaging device for skin diagnostics in healthcare. | |
| nurugo.com | 2014 | Seoul, South Korea | – | – | Develops smartphone-attachable devices for fingerprint recognition, skin diagnosis, and microscopy. | |
| novatechcorp.com | 1997 | Portsmouth, United States | – | – | Biophysical skin properties are measured non-invasively using devices and software. | |
| mimlabs.com | 2008 | Valhalla, United States | $3.9M | – | Digital image analysis for skin and hair conditions is offered. | |
| microelastic.com | 2015 | Durham, United States | – | – | Tissue elasticity is measured ultrasonically by MicroElastic's device. | |
| pixience.com | 2012 | Toulouse, France | – | – | Digital dermoscopes are developed for skin lesion analysis and monitoring. |
Detailed competitors of Caliber I.D.
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Caliber I.D.
The website of Caliber I.D. (caliberid.com) receives about 1.5K visits a month.
- Monthly visits1.5K
▼ 15.7% vs previous month
Latest news on Caliber I.D.
Complete news archive for Caliber I.D.
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Caliber I.D.
10 companies that operate in the same segment as Caliber I.D. (Dermatology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Neurotoxin products for aesthetic and therapeutic skin treatments are developed. | 2002 | Newark, New Jersey, United States | USD 154.56 M | USD 234.04 M | 597 | |
Diagnostic tests for cancer prognosis are provided. | 2008 | Friendswood, Texas, United States | USD 61.97 M | USD 344.23 M | 761 | |
Developer of drugs for treating dermatology diseases | 1908 | Copenhagen, Denmark | USD 560.38 M | – | – | |
Skincare, beauty, and wellness services provided by VLCC across multiple countries. | 1989 | Delhi, Delhi, India | – | – | – | |
Adhesive patch biopsies for skin cancer detection are provided. | 1996 | San Diego, California, United States | USD 24.37 M | USD 15.3 M | 259 | |
AI-powered drug discovery platform for various diseases | 2016 | New York, New York, United States | USD 608 M | – | – | |
Immunotherapeutic solutions for dermatological conditions are developed. | 2016 | Westlake Village, California, United States | USD 94.5 M | USD 376.07 M | 342 | |
Targeted small molecules are developed for oncology treatments. | 2010 | Singapore, Singapore | USD 100 M | – | – | |
Pharmaceutical formulations for dermatology, gastroenterology, and wellness are manufactured. | 2014 | Pune, Maharashtra, India | USD 25.97 M | USD 18.15 M | 508 | |
Novel dermatologic therapies are developed for skin conditions. | 2012 | Malvern, Pennsylvania, United States | USD 82 M | USD 7.83 M | 64 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Caliber I.D.
Caliber I.D. was founded in 1991 and raised its 1st funding round 18 years after it was founded.
Caliber I.D. is headquartered in Andover, United States. It is registered at Andover, Massachusetts, United States.
Caliber I.D. is a funded company, having raised a total of $1.08M across 2 funding rounds to date. The company's 1st funding round was a Unspecified of $1.08M, raised on Nov 2009.
Caliber I.D. has 18 employees.
Caliber I.D. was founded in 1991 in Andover, United States, within the medical imaging sector. Screening devices for dermatologists are offered, enabling real-time imaging and diagnosis of cells without biopsies. An integrated platform of tools and technology is provided for routine cell diagnosis, with emphasis on accuracy and online backup capabilities. Operations focus on diagnostic support in dermatology.
Caliber I.D.'s top competitors include Phase Focus, MedX Health and MicroElastic.
Caliber I.D. offers VivaScope, VivaNet, VivaCam, and VivaScan.
Yes, Caliber I.D. is publicly traded on OTC under the ticker symbol LCDX.
Caliber I.D. operates through Caliber Imaging & Diagnostics, Inc..